PRKAG1

Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 1

Gene Information Card

Symbol PRKAG1
Full Name Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 1
Gene Type protein-coding
Chromosomal Location 12q13.12
NCBI Gene ID 5571 ncbi.nlm.nih.gov/gene/5571
Ensembl ID ENSG00000111713
UniProt ID P54619
OMIM ID 602742
HGNC ID 9385
Aliases AMPK gamma1, AMPKG, MGC2615

Description

PRKAG1 encodes the gamma-1 regulatory subunit of AMP-activated protein kinase (AMPK), a heterotrimeric complex that acts as a cellular energy sensor. AMPK is activated under low-energy conditions (high AMP/ATP ratio) and regulates key metabolic pathways including glucose uptake, fatty acid oxidation, and protein synthesis. Mutations in PRKAG1 can lead to altered AMPK activity and are associated with cardiac and metabolic disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Glycogen storage cardiomyopathy (PRKAG1-related) Loss-of-function or dominant-negative mutations impair AMPK regulation, leading to excessive glycogen accumulation in cardiac myocytes and ventricular pre-excitation. ClinVar, OMIM
Wolff-Parkinson-White syndrome Gain-of-function or aberrant AMPK signaling disrupts cardiac conduction system development, causing accessory pathways. ClinVar, OMIM
Familial hypertrophic cardiomyopathy Dysregulated AMPK activity promotes cardiac hypertrophy and glycogen storage. ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.5 Medium
Skeletal muscle 8.3 Medium
Liver 6.1 Low
Brain 5.4 Low
Pancreas 4.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 10.2 Cervical cancer cell line
HepG2 7.5 Hepatocellular carcinoma
K562 6.8 Leukemia cell line
A549 5.9 Lung carcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.245G>A (p.Arg82Gln) Missense <0.01% Dominant-negative; reduces AMP binding and AMPK activation
c.433C>T (p.Arg145Trp) Missense <0.01% Gain-of-function; increases AMPK activity in heart
c.592G>A (p.Glu198Lys) Missense <0.01% Loss-of-function; impairs heterotrimer formation
Mutation functional classification

Loss of Function (LOF)

Mutations that reduce AMP binding or disrupt subunit interaction, leading to decreased AMPK activity and glycogen accumulation.

Gain of Function (GOF)

Mutations that enhance AMPK activity, often associated with cardiac conduction abnormalities.

Dominant Negative (DN)

Mutations that produce a defective gamma subunit that interferes with wild-type AMPK complex function.

Gene Ontology (GO)

• AMP-activated protein kinase activity • protein heterodimerization activity
• ATP binding • cellular response to glucose starvation
• regulation of fatty acid oxidation • glycogen metabolic process

Pathways

AMPK signaling pathway (KEGG: hsa04152)
Insulin signaling pathway (KEGG: hsa04910)
Adipocytokine signaling pathway (KEGG: hsa04920)

Protein Summary

The PRKAG1 protein (AMPK gamma1) is a regulatory subunit of AMPK. It contains four cystathionine beta-synthase (CBS) domains that bind AMP, ADP, and ATP, allowing the complex to sense cellular energy status. Binding of AMP promotes activation by upstream kinases, while ATP binding inhibits activation. The gamma1 isoform is widely expressed, with highest levels in heart and skeletal muscle.

Related Products

Product name Cat.No. Species Gene ID
PRKAG1 Knockout HEK293 Cell Line EDJ-KQ1449 Human 5571 Details Get a Quote
PRKAG1 Knockout A-549 Cell Line EDJ-KQ21001 Human 5571 Details Get a Quote
PRKAG1 Knockout HCT 116 Cell Line EDJ-KQ21002 Human 5571 Details Get a Quote
PRKAG1 Knockout HeLa Cell Line EDJ-KQ21003 Human 5571 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: